Results 31 to 40 of about 22,022 (240)

Encapsulation of nystatin in nanoliposomal formulation: characterization, stability study and antifungal activity against Candida albicans

open access: yesPharmaceutical and Biomedical Research, 2016
In this study, nystatin liposomal formulation was prepared and characterized. The physicochemical properties of formulations including vesicle size, drug entrapment stability and in vitro release were studied.
Ebrahim Saadat   +2 more
doaj   +1 more source

Nystatin

open access: yesReactions Weekly, 2022
In this column, Sharon Rees aims to refresh knowledge and interest in some of the commonly used drugs in a series of tweets. This month she is talking about #nystatin
  +5 more sources

Studies on the biosynthesis of antibiotic nystatin with emphasis on regulation [PDF]

open access: yes, 2013
Nystatin is an antifungal polyene macrolide antibiotic produced by Streptomyces noursei, first described in 1950 (Hazen and Brown, 1950). Nystatin is currently being used for treatment of superficial fungal infections, and is considered a medically ...
Sekurova, Olga
core   +2 more sources

Accessing Nystatin through Mariculture [PDF]

open access: yes, 2021
Understanding our oceans and their marine ecosystems has enabled the development of sustainable systems for mariculture. While the bulk of studies to date have focused on the production of food, its remarkable expanse has inspired the translation of ...
James J. La Clair, La Clair, James
core   +1 more source

Semisynthetic Amides of Amphotericin B and Nystatin A1: A Comparative Study of In Vitro Activity/Toxicity Ratio in Relation to Selectivity to Ergosterol Membranes

open access: yesAntibiotics, 2023
Polyene antifungal amphotericin B (AmB) has been used for over 60 years, and remains a valuable clinical treatment for systemic mycoses, due to its broad antifungal activity and low rate of emerging resistance.
Anna Tevyashova   +11 more
doaj   +1 more source

In Vitro Evaluation of Pomegranate (Punica granatum) Peel Extract against Candida krusei as an alternative agent to antifungal medicines

open access: yesZanco Journal of Pure and Applied Sciences, 2022
Vulvovaginal Candidiasis (VVC) is a fungal infection of the genital mucosa caused by Candida spp. This is an investigation on the isolation of Candida krusei from cervical-VVC patients in Erbil hospitals, Iraqi Kurdistan, and its identification using ...
nareen faqi, Hero M. Ismael
doaj   +1 more source

Comparison of Antifungal Susceptibility Basil Leaves Extract (Ocimum sanctum Linn.), Eugenol, and Nystatin against Isolates of Candida spp. as Important Agent causing Oral Candidiasis in HIV/AIDS Patient

open access: yesBerkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology), 2022
Background: Oral candidiasis is an infection caused by Candida sp. in areas of the oral mucosa that are often found in HIV/AIDS patients. Increased antifungal resistance, it was important to find new antifungal candidates, especially from natural ...
Emma Hidayati Sasmito   +8 more
doaj   +1 more source

Polyene macrolide antifungal drugs trigger interleukin-1β secretion by activating the NLRP3 inflammasome. [PDF]

open access: yes, 2011
The use of antimycotic drugs in fungal infections is based on the concept that they suppress fungal growth by a direct killing effect. However, amphotericin and nystatin have been reported to also trigger interleukin-1β (IL-1β) secretion in monocytes but
Rupanagudi Khader Valli   +15 more
core   +1 more source

Water-Soluble Nystatin and Derivative

open access: yes, 2022
Fungal infections are increasingly causing more morbidity and mortality, especially for immunocompromised people. In recent years, there is growing evidence that new medicine-resistant fungal strains are posing added challenges in the clinic. Nystatin is
Michal Levin-Khalifa (11977729)   +5 more
core   +1 more source

Enhancement of the antifungal activity of some antimycotics by farnesol and reduction of Candida albicans pathogenicity in a quail model experiment [PDF]

open access: yesVeterinary World, 2022
Background and Aim: Clinical strains of microorganisms, including pathogenic yeast-like fungi (YLF), are resistant to currently used antifungal agents. Thus, it is relevant to study the combinations of existing antimicrobial drugs and a medicinal extract
Nadezhda Sachivkina   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy